CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to BMY

Nivolumab 480mg + Ipilimumab

Phase 2
Bristol-Myers Squibb Company (BMY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Apr '27
BMYPhase 2

Nivolumab 480mg + Ipilimumab Phase 2 Est. Readout

Nivolumab 480mg + Ipilimumab
Apr 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Colorectal Cancer Metastatic

View Full Landscape
Drug Information

Target Indication

Colorectal Cancer Metastatic

Clinical Trial

NCT04730544

Last updated: 10/2/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.